Selamectin (Revolution)

Selamectin, marketed under the brand name Revolution, represents one of the most versatile topical antiparasitic medications available in veterinary medicine, providing protection against a remarkably broad spectrum of both internal and external parasites through a single monthly application. This macrocyclic lactone compound belongs to the avermectin class of antiparasitics, sharing structural and mechanistic similarities with ivermectin while demonstrating an enhanced safety profile that allows for use in breed-sensitive dogs when administered at labeled doses. Revolution uniquely combines flea prevention, heartworm prevention, ear mite treatment, sarcoptic mange control, and activity against certain intestinal parasites in one convenient topical formulation, making it an excellent choice for comprehensive parasite protection in dogs with multiple prevention needs.

The mechanism of action of selamectin involves disruption of glutamate-gated chloride channels in the nervous systems of target parasites, leading to increased cell membrane permeability to chloride ions, hyperpolarization of nerve and muscle cells, paralysis, and death. This mechanism affects both arthropod parasites such as fleas and mites and nematode parasites including heartworm larvae and certain intestinal worms. Following topical application, selamectin enters systemic circulation in sufficient concentrations to kill developing heartworm larvae (Dirofilaria immitis) while also distributing to the skin's sebaceous glands, providing sustained release that maintains flea-killing activity throughout the dosing interval. This dual distribution pathway accounts for Revolution's effectiveness against both internal and external parasites.

Revolution is available exclusively as a prescription topical spot-on solution, requiring veterinary authorization before dispensing due to its heartworm prevention indication and the need for heartworm testing before initiating prevention. The product comes in several weight-based formulations to ensure appropriate dosing across the wide range of canine body sizes, from puppies as young as 6 weeks of age to adult dogs of all sizes. The topical application provides ease of administration compared to oral medications while achieving systemic distribution necessary for heartworm prevention. Monthly application maintains consistent protection against all target parasites when used according to the prescribed schedule.

The safety profile of selamectin has been extensively studied and demonstrates a wide margin of safety in dogs, including those breeds sensitive to other avermectin compounds. Unlike ivermectin at higher doses, selamectin at labeled topical doses has not demonstrated toxicity in dogs with the MDR1 (ABCB1) gene mutation that causes sensitivity to certain antiparasitics in herding breeds. This safety advantage makes Revolution a valuable option for Collies, Australian Shepherds, and related breeds requiring comprehensive parasite protection. However, veterinary guidance remains essential for appropriate product selection and monitoring, particularly given the prescription requirement and the importance of heartworm testing before prevention initiation.

The primary indication for selamectin is prevention of heartworm disease caused by Dirofilaria immitis, one of the most serious parasitic conditions affecting dogs in many regions worldwide. Heartworm disease is transmitted by mosquitoes carrying infective heartworm larvae, and without prevention, infected dogs can develop severe cardiovascular and pulmonary disease that is difficult and expensive to treat and can be fatal. Selamectin kills the immature larval stages of heartworm (L3 and L4 larvae) before they can mature into adult worms in the heart and pulmonary arteries. Monthly application beginning before mosquito exposure and continuing throughout the transmission season, or year-round in many regions, provides effective heartworm prevention when administered consistently.

Flea prevention and treatment represent another major indication for selamectin. The product kills adult fleas and prevents flea eggs from hatching for one month following application. This dual activity against adult fleas and eggs helps break the flea life cycle more effectively than adulticidal products alone, as it addresses the reproductive potential of any fleas that contact the treated dog. Dogs with flea allergy dermatitis benefit from Revolution's flea control, as maintaining a flea-free state is essential for managing this hypersensitivity condition. The flea control efficacy, combined with heartworm prevention, makes Revolution a convenient option for dogs requiring protection against both parasites.

American dog tick (Dermacentor variabilis) control is an additional labeled indication for selamectin, though it should be noted that Revolution does not provide the broad-spectrum tick protection of some other products. Dogs requiring protection against multiple tick species, particularly in areas where Lyme disease, ehrlichiosis, or anaplasmosis are prevalent, may need supplemental tick prevention or alternative products with broader acaricidal activity. The American dog tick is the primary vector for Rocky Mountain spotted fever and tularemia, so protection against this species provides meaningful disease prevention in endemic areas.

Ear mite (Otodectes cynotis) treatment and control represent an important indication for selamectin. Ear mites cause significant discomfort, intense itching, head shaking, and ear inflammation in affected dogs. A single application of Revolution is often effective for treating ear mite infestations, though some cases may require additional application. The systemic activity of selamectin reaches mites within the ear canal without requiring direct ear treatment, simplifying therapy for this sometimes challenging condition.

Sarcoptic mange (Sarcoptes scabiei) treatment is facilitated by selamectin's miticidal activity. Sarcoptic mange causes severe itching, hair loss, and skin crusting and is highly contagious between dogs and can temporarily affect humans. Revolution provides an effective and convenient treatment option, typically requiring two monthly applications for resolution. Additionally, selamectin controls certain intestinal parasites including roundworms (Toxocara canis) and hookworms (Ancylostoma caninum), adding intestinal parasite control to its comprehensive protection profile.

The dosing protocol for selamectin follows a weight-based approach using pre-measured applicators designed to deliver the appropriate dose for dogs within specific weight ranges. Revolution for dogs is available in formulations for puppies and dogs up to 5 pounds, 5.1 to 10 pounds, 10.1 to 20 pounds, 20.1 to 40 pounds, 40.1 to 85 pounds, and 85.1 to 130 pounds. Dogs weighing more than 130 pounds require an appropriate combination of tubes to achieve the recommended dosing of 6 mg/kg minimum. Accurate weight determination is essential for proper product selection, as underdosing may result in inadequate protection, particularly for heartworm prevention where complete larval kill is critical. Dogs should be weighed before each monthly application, especially puppies experiencing rapid growth.

The standard application interval for Revolution is once every 30 days for continuous protection against all target parasites. This monthly schedule must be maintained consistently to ensure heartworm prevention efficacy, as gaps in protection allow transmitted larvae to survive and potentially mature into adult heartworms. Unlike some flea-only products where occasional missed doses may have limited consequences, missed doses of heartworm preventives create genuine disease risk. Setting calendar reminders, using smartphone applications, or establishing other reminder systems helps ensure consistent monthly application throughout the year or heartworm transmission season as appropriate for geographic location.

Treatment duration for heartworm prevention depends on regional mosquito activity and transmission patterns. In many areas of the United States, year-round prevention is recommended regardless of seasonal variation, as unusually warm periods can extend transmission seasons and indoor mosquitoes can transmit heartworm year-round. Dogs in areas with distinct seasonal transmission may receive prevention from one month before mosquito emergence through one month after the first killing frost. The American Heartworm Society recommends year-round prevention for all dogs in all regions. For ear mites and sarcoptic mange, treatment typically continues for one to two monthly applications depending on response.

Proper administration technique ensures optimal product absorption and efficacy. The dog should be standing or held still, and the hair should be parted at the base of the neck in front of the shoulder blades to expose the skin. The entire contents of the applicator tube should be squeezed directly onto the skin in a single spot. Direct skin contact is essential, as product remaining on the hair rather than reaching the skin results in reduced systemic absorption and potentially inadequate heartworm protection. The application site should not be touched until completely dry, and bathing should be avoided for at least 2 hours after application, though the product is water-fast once dry.

Before initiating heartworm prevention with Revolution, dogs 6 months of age or older should be tested for existing heartworm infection. Administering prevention to dogs with adult heartworm infections does not kill adult worms and can potentially cause adverse reactions in heavily infected dogs. Annual heartworm testing is recommended even for dogs on consistent prevention to verify efficacy and detect any breakthrough infections early. Puppies younger than 6 months can generally begin prevention without testing if they have been on prevention since 6 weeks of age.

Missed doses should be applied as soon as the oversight is discovered, and monthly dosing should continue from that date. The effectiveness of heartworm prevention decreases significantly when doses are missed by more than two weeks. If multiple doses have been missed during transmission season, veterinary consultation is essential to determine whether heartworm testing should be performed before resuming prevention. Never double up on doses to compensate for missed applications.

Selamectin demonstrates an excellent safety profile in dogs when used according to label directions, with adverse effects being uncommon in most animals. The product has been tested at multiples of the recommended dose with minimal toxicity, establishing a wide margin of safety. Clinical studies and extensive post-market surveillance have confirmed that most dogs tolerate monthly Revolution application without any observable adverse effects. However, individual sensitivity varies, and awareness of potential side effects allows for appropriate monitoring and response when reactions occur.

The most commonly reported side effects involve transient reactions at or near the application site. Some dogs develop temporary hair loss, skin irritation, redness, or pruritus at the location where the product was applied. These local reactions typically resolve within a few days without intervention. A moist or clumped appearance of hair at the application site immediately following application is normal and expected with topical spot-on formulations. Some dogs may scratch at or attempt to rub the application site due to the sensation of the liquid on their skin, behavior that usually subsides as the product dries and absorbs.

Gastrointestinal effects have been reported uncommonly following selamectin application. Some dogs experience transient vomiting, diarrhea, or decreased appetite in the hours to days following application. These effects are typically mild and self-limiting, resolving without specific treatment. If gastrointestinal signs are severe or persistent, veterinary consultation is appropriate. Oral ingestion of the product through licking the application site before drying or grooming other treated pets may increase the likelihood of gastrointestinal upset.

Neurological effects are rare with selamectin at labeled topical doses but have been reported in post-market surveillance. Signs may include ataxia, tremors, or behavioral changes. Unlike ivermectin at higher doses, selamectin has not demonstrated significant toxicity in dogs with the MDR1 gene mutation when used at labeled doses, making it one of the safer avermectin-class drugs for herding breeds. However, any neurological signs following application warrant veterinary evaluation. Dogs receiving very large overdoses, whether accidental or through ingestion of multiple doses, may be at increased risk for neurological effects and should receive veterinary attention.

Hypersalivation or drooling may occur if dogs lick the application site before the product has dried. The taste of selamectin can cause excessive salivation that typically resolves once the exposure ends. Preventing licking through appropriate application site selection and brief observation following application minimizes this concern. Allergic reactions including facial swelling, hives, or difficulty breathing are rare but have been reported and require immediate veterinary attention. Dogs that have experienced adverse reactions to Revolution should not receive subsequent applications, and alternative parasite prevention should be selected.

The primary consideration before using selamectin is confirmation that the dog is not harboring an existing adult heartworm infection. While heartworm-positive status is not an absolute contraindication for selamectin use, administering macrocyclic lactone preventives to dogs with significant adult worm burdens can potentially cause adverse reactions related to rapid die-off of circulating microfilariae. Dogs 6 months of age or older should be tested for heartworm infection before initiating Revolution, and any dog with a positive or suspect test result should be evaluated by a veterinarian before beginning prevention. Treatment of existing heartworm infection requires different protocols than prevention of new infection.

Known hypersensitivity or previous allergic reaction to selamectin or other avermectin compounds represents a contraindication for use. Dogs that have experienced adverse reactions to Revolution or similar products should not receive subsequent applications. Prior to initial use, owners should inform their veterinarian of any previous adverse reactions to topical antiparasitic products. While cross-reactivity between different macrocyclic lactones is not well documented, veterinary guidance ensures appropriate product selection for dogs with histories of adverse reactions.

Organ dysfunction, while not an absolute contraindication, warrants veterinary assessment for dogs with significant hepatic impairment. Selamectin undergoes hepatic metabolism, and dogs with severe liver disease may have altered drug handling. Dogs with diagnosed liver disease should have their parasite prevention program individually evaluated. Renal dysfunction is generally less of a concern, as selamectin is primarily eliminated through fecal excretion rather than renal pathways. However, any dog with significant organ dysfunction should have comprehensive veterinary evaluation before initiating new medications.

Age restrictions require attention to the minimum age for selamectin use. Revolution is approved for use in puppies 6 weeks of age and older, making it one of the earliest-starting heartworm prevention options available. Puppies younger than 6 weeks should not receive the product. There is no maximum age restriction, and senior dogs generally tolerate selamectin well when otherwise healthy. Very young, very old, or debilitated animals may warrant additional veterinary assessment before treatment.

Pregnancy and lactation status should be disclosed to the prescribing veterinarian. Selamectin has been shown to be safe for use in breeding, pregnant, and lactating dogs in reproductive studies, and the product is labeled for use in these populations. However, individual circumstances may influence the risk-benefit assessment for specific patients. Dogs intended for breeding should have their complete parasite prevention program reviewed with a veterinarian familiar with reproductive considerations. Sick, debilitated, or underweight dogs require veterinary evaluation before initiating treatment with any new medication.

Complete disclosure of all medications, supplements, and other parasite control products to the prescribing veterinarian ensures optimal safety and efficacy of selamectin treatment. As a prescription medication with systemic absorption, Revolution has potential for interactions with other compounds that share metabolic pathways or mechanisms of action. Understanding these interactions helps veterinarians design comprehensive and safe parasite control programs while optimizing therapeutic outcomes.

Interactions between multiple heartworm prevention products warrant particular attention. Dogs should not receive multiple heartworm preventive medications simultaneously, as this provides no additional efficacy benefit while potentially increasing the risk of adverse effects. When transitioning between different heartworm preventives, the new product is typically started at the time the previous product's monthly dose would have been due. Dogs receiving Revolution do not need additional heartworm prevention products. Similarly, combining Revolution with other macrocyclic lactone products such as ivermectin, milbemycin, or moxidectin-containing products should be avoided unless specifically directed by a veterinarian.

Concurrent use of other flea and tick products with Revolution may be appropriate in some circumstances but requires veterinary guidance. Dogs requiring tick protection beyond the American dog tick coverage provided by Revolution may need additional tick control through products such as fipronil, permethrin (in cat-free households), or oral isoxazoline compounds. The addition of such products should be discussed with the prescribing veterinarian to ensure safety and avoid unnecessary chemical exposure. Topical permethrin-containing products can generally be used with Revolution in dog-only households, but appropriate timing and application site separation should be considered.

P-glycoprotein substrate interactions deserve consideration for dogs receiving medications that affect or are affected by the MDR1 (P-glycoprotein) transporter. While selamectin at labeled doses appears safe in MDR1-mutant dogs, concurrent use of other P-glycoprotein substrates or inhibitors could theoretically alter drug handling. Medications including cyclosporine, ketoconazole, and certain cardiac drugs affect P-glycoprotein function and should be discussed with the prescribing veterinarian. Dogs receiving chemotherapy agents that are P-glycoprotein substrates require careful evaluation of any concurrent medications.

Dietary supplements commonly used in dogs typically do not interact significantly with selamectin. Joint supplements, omega fatty acids, probiotics, and most herbal preparations can generally be continued without modification. However, complete supplement disclosure allows veterinarians to identify any potential concerns. The timing of oral medications and supplements relative to Revolution application is generally not critical, as the topical application results in systemic absorption over hours to days rather than requiring gastrointestinal absorption timing considerations.

General precautions for selamectin use begin with ensuring appropriate product selection based on accurate body weight and verification of heartworm-negative status before initiating prevention. Dogs should be weighed before each monthly application to confirm the correct formulation, as weight changes can occur between treatments, particularly in growing puppies. Using a product intended for dogs smaller than the patient results in underdosing that may compromise heartworm prevention efficacy. Heartworm testing before initial prevention and annually thereafter confirms negative status and detects any breakthrough infections early when they are more treatable.

Breed-specific considerations for selamectin are notably less restrictive than for some other macrocyclic lactone compounds. Unlike ivermectin at higher doses, selamectin at labeled topical doses has not demonstrated toxicity in dogs with the MDR1 (ABCB1) gene mutation that causes sensitivity to certain antiparasitics in herding breeds. This safety profile has been specifically studied and documented. Collies, Australian Shepherds, Shetland Sheepdogs, Border Collies, Old English Sheepdogs, and related breeds, as well as mixed breeds with herding dog heritage, can generally receive Revolution at recommended doses without heightened risk. However, veterinary guidance remains appropriate for any dog with known MDR1 mutation status or breed-related sensitivity concerns.

Environmental and handling precautions protect household members during product application. The product should be applied in a well-ventilated area, and handlers should avoid direct contact with the liquid formulation. Hands should be washed thoroughly after application. Children should not handle the product or touch the application site until completely dry. The product dries relatively quickly compared to some topical formulations, but observation for several hours following application helps ensure the application site is not disturbed before the product absorbs.

Monitoring during treatment encompasses both safety observation and efficacy verification. Following application, dogs should be watched for signs of local skin reactions, gastrointestinal upset, or any unusual behavioral changes. Most side effects, if they occur, manifest within 24 to 48 hours of application. Annual heartworm testing verifies prevention efficacy and enables early detection of any breakthrough infections. For dogs being treated for ear mites or sarcoptic mange, follow-up evaluation confirms resolution and determines whether additional treatment is needed.

Special populations requiring additional consideration include senior dogs, very young puppies approaching the minimum age threshold, immunocompromised animals, and dogs with concurrent health conditions. Geriatric dogs may have age-related changes in drug metabolism or elimination that warrant veterinary evaluation before initiating any new medication. Puppies should meet the minimum 6-week age requirement before treatment. Dogs receiving immunosuppressive therapy or those with immune-mediated diseases should have their overall health status reviewed with their veterinarian.

Proper storage of selamectin products maintains product potency and safety throughout the shelf life. Revolution should be stored at controlled room temperature below 86 degrees Fahrenheit (30 degrees Celsius), protected from excessive heat. Storage locations subject to significant temperature fluctuations, such as vehicles, garages, or outdoor storage areas, should be avoided, as elevated temperatures can affect formulation stability and active ingredient potency. Direct sunlight exposure should also be avoided through storage in a dark location such as a closed cabinet or drawer.

Formulation-specific handling requirements for this prescription spot-on product include maintaining applicator tubes sealed in original packaging until immediately before use. The individual applicator tubes are designed to protect the liquid formulation from air exposure and evaporation. Once an applicator is opened, the entire contents should be applied immediately, as partial use and storage of opened applicators is not recommended and may result in inaccurate dosing. Unused applicators should remain sealed and can be stored for future monthly applications within the expiration date printed on the packaging. Before each use, applicators should be inspected for any damage, leakage, or changes in the formulation appearance that might indicate product degradation.

Safety considerations for storage and disposal protect household members and the environment. As a prescription medication, Revolution should be stored securely away from children and pets, who should not have access to pharmaceutical products. The original packaging should be retained for reference regarding active ingredients, dosing information, and veterinary contact information. Expired or unused product should be disposed of according to veterinary guidance or local regulations for pharmaceutical waste. Many veterinary clinics and pharmacies accept unused medications for proper disposal. The product should not be disposed of in household trash where it could be accessed by children or animals, or in waterways where it could affect aquatic organisms. Empty applicator tubes can typically be disposed of in regular household waste after ensuring all product has been applied and the tubes are completely empty.

One of the most significant advantages of selamectin compared to other macrocyclic lactone antiparasitics is its documented safety profile in breeds carrying the MDR1 (ABCB1) gene mutation. Unlike ivermectin at higher doses, which can cause severe neurological toxicity in affected dogs, selamectin at labeled topical doses has been specifically studied and found safe in MDR1-mutant dogs. This makes Revolution an excellent choice for herding breeds including Collies (in which up to 70% may carry the mutation), Australian Shepherds, Shetland Sheepdogs, Border Collies, Old English Sheepdogs, English Shepherds, Longhaired Whippets, Silken Windhounds, and mixed breeds with herding dog heritage. Dogs with confirmed MDR1 mutation through genetic testing can receive selamectin with appropriate confidence.

Beyond MDR1 considerations, breed-specific sensitivities to topical products may relate to coat and skin characteristics. Breeds with sparse haircoats or thin skin, such as Chinese Cresteds, Whippets, Italian Greyhounds, or hairless varieties of other breeds, may be more prone to local skin reactions at application sites. These dogs should be monitored following application for signs of irritation. Conversely, breeds with extremely dense double coats, such as Siberian Huskies, Alaskan Malamutes, Samoyeds, or Chow Chows, require careful application technique to ensure the product reaches the skin for proper absorption. Parting the coat thoroughly and applying directly to exposed skin optimizes systemic absorption necessary for heartworm prevention.

Size considerations significantly influence product selection across the wide weight range of domestic dogs. Giant breeds including Great Danes, Irish Wolfhounds, English Mastiffs, and Saint Bernards exceeding the 130-pound maximum of standard formulations require combination of appropriate tubes to achieve adequate dosing. Veterinary guidance ensures appropriate dosing for these large patients. At the opposite end of the spectrum, toy breeds and small puppies require careful weight verification to ensure appropriate formulation selection. The smallest formulation covers dogs up to 5 pounds, and accurate weighing prevents both underdosing that could compromise heartworm prevention and unnecessary overdosing.

Age considerations affect both product selection and safety. Revolution is approved for puppies as young as 6 weeks of age, making it one of the earliest-starting comprehensive parasite prevention options available. This early initiation is particularly valuable for puppies in endemic heartworm areas where protection should begin as soon as possible. Giant breed puppies experience rapid growth and may transition through multiple weight categories quickly, requiring frequent reassessment of appropriate formulation. Senior dogs generally tolerate selamectin well, and there is no maximum age restriction for healthy geriatric patients.

Same-class alternatives within the macrocyclic lactone category include other avermectin and milbemycin compounds used for heartworm prevention. Ivermectin-based products (Heartgard, Heartgard Plus) provide heartworm prevention through oral administration but require caution in MDR1-sensitive breeds at higher doses. Milbemycin oxime (Interceptor, Sentinel) offers oral heartworm and intestinal parasite prevention. Moxidectin appears in products such as ProHeart (injectable long-acting prevention) and Advantage Multi (topical combination with imidacloprid). Each alternative has distinct advantages regarding spectrum of activity, route of administration, and safety profiles in sensitive breeds. The choice among macrocyclic lactones often depends on desired spectrum, administration preference, and any breed-related sensitivity concerns.

Different class options for flea control without heartworm prevention include products that may be appropriate when heartworm prevention is addressed separately or not needed. Fipronil (Frontline) provides phenylpyrazole-based flea and tick control. Imidacloprid (Advantage) offers neonicotinoid flea control. Oral isoxazoline compounds including afoxolaner (NexGard), fluralaner (Bravecto), sarolaner (Simparica), and lotilaner (Credelio) provide flea and tick protection through different mechanisms. Some dogs may receive Revolution for heartworm prevention with supplemental tick products to address tick species beyond the American dog tick coverage provided by selamectin alone.

Complementary approaches enhance the effectiveness of selamectin within a comprehensive parasite management program. Environmental flea control through regular vacuuming, washing pet bedding, and treating home environments addresses flea populations beyond what monthly topical treatment eliminates from the pet. For dogs requiring broader tick protection, supplemental tick control products may be used with Revolution under veterinary guidance. Intestinal parasite control beyond the roundworm and hookworm coverage of Revolution may require periodic broad-spectrum deworming. Veterinary guidance ensures the most appropriate combination of products based on individual risk factors, regional parasite prevalence, lifestyle considerations, and any breed-related safety concerns, while avoiding unnecessary duplication of heartworm prevention.